Acadia Pharma Q2 2025 Earnings Preview

17 hours ago 1

Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q2 earnings results on Wednesday, August 6th, after market close.
The consensus EPS Estimate is $0.14 and the consensus Revenue Estimate is $262.07M (+8.3% Y/Y).
Over the last 3 months, EPS estimates have seen

Recommended For You